Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Auxiliary. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel green route for chiral 10-camphorsulfoxazine using hydroxylamine sulfonic acid. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing.
Patent CN1070647A details a novel asymmetric synthesis for pseudophrynaminol. Discover cost reduction in API intermediate manufacturing and high-purity supply chain solutions.
Patent CN114375290A details scalable routes for Factor XIa inhibitor intermediates. Discover cost-effective manufacturing and supply chain advantages for pharmaceutical production.
Patent CN1028361C details asymmetric synthesis of 2(S)-glutaric acid intermediates, offering high purity and scalable routes for cardiovascular drug manufacturing.
Patent CN105111169A reveals a streamlined route for Sofosbuvir intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Patent CN113336726B details a novel synthesis of (R)-3-propyl-γ-butyrolactone using chiral auxiliaries, offering high purity and cost-effective manufacturing for API intermediates.
Novel 3-step route using L-camphorsulfonamide. High yield, cost-effective alternative to noble metal catalysis for API manufacturing.
Patent CN110437216B details a cost-effective Lamivudine route using L-menthol, offering high yield and purity for pharmaceutical intermediate manufacturers.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Novel patent CN113264839A details a high-ee route to levo-terbutaline using tert-butyl sulfinamide, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Novel maleimide-based route for high-purity calcium antagonist intermediates. Reduces cost and improves scalability for API manufacturing.
Patent CN102477016B reveals asymmetric synthesis for Tapentadol intermediates. Achieve high chiral purity and cost reduction in pharmaceutical manufacturing.
Patent CN104781243A details a novel chiral synthesis for ribonolactone intermediates. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Patent CN109438432B details a green emtricitabine synthesis using L-menthol. Offers cost reduction in antiviral API manufacturing and high-purity intermediates.
Patent CN102212041A details a cost-effective synthesis of chiral cyclic beta-amino aryl butyric acid derivatives with high optical purity suitable for pharmaceutical manufacturing.
Novel method for avibactam intermediate using L-camphorsulfonamide. High yield, stereoselective route for reliable pharmaceutical intermediate supplier.
Patent CN102212015A details a cost-effective chiral induction method for high-purity beta-amino acids, offering significant supply chain advantages for API manufacturing.
Patent CN101935309B reveals a high-yield route for ezetimibe intermediates using a tricyclic indene oxazole auxiliary, offering superior stereoselectivity and cost-effective manufacturing solutions.
Patent CN115197115A details a novel chiral synthesis route offering high optical purity and scalable manufacturing for pharmaceutical intermediates and cost reduction.
Novel chiral intermediate synthesis for Moxifloxacin. High purity, scalable process, cost-effective manufacturing solution for global supply chains.